With the enhance in popularity of self-injection products, a number of market stakeholders have attempted to innovate the units by incorporating superior functions to enhance patient compliance and make certain correct dosing. The ongoing R&D activity in this domain has led to a significant improve in the amount of patents filed / granted connected with novel massive volume wearable self-injection devices. In purchase to continuously broaden their intellectual capital to sustain prolonged term growth, it is critical for developers to safeguard their intellectual assets by means of patents.



In excess of the previous number of many years, there has been a regular boost in the amount of patents linked with these gadgets. In reality, right after 2017, the number of patents filed / granted has enhanced substantially each and every yr, across the globe. Exclusively in 2019, the highest quantity of patents were published globally. Notable examples of the proprietary technologies, used in big volume wearable injectors, contain (in alphabetical purchase) ECell technology (SteadyMed Therapeutics), SmartGuard engineering (Medtronic) and VapourSoft technologies (Bespak).





It is well worth highlighting that bulk (62%) of these patents are applications (not having acquired approval however), followed by granted patents (38%). Of these, majority of the patents (85%) were filed / granted in North America of these, in excess of 2,200 were filed / granted in the US in the time period among January 1985 and January 2020. This was followed by Asia-Pacific and Europe, in which 9% and 6% patents were filed / granted, respectively. The information signifies that besides North America, development action is also at present taking location in Asia-Pacific (particularly in Australia and China) and European areas. It is really worth mentioning that more than 500 patent applications (accounting for around 17% of the total) have been filed with Globe Intellectual Residence Organization (WIPO), in the offered time time period.




click for info Regardless of the truth that a large number of patents have been filed not too long ago (and therefore obtaining a long remaining patent daily life), only .3% of the complete patents have a considerably larger relative valuation. This is largely simply because of the comparatively lower citations linked with these patents, major to reduced patent worth.



Examination of key phrases in these patents exposed the popularity of needle retraction techniques in patch pumps due to their ability to minimize needle-stick injuries for delivering a drug more than a prolonged time period of time (basal dosing) or short time time period (bolus dosing). The word cloud highlights that majority of the wearable injectors are wireless devices that use sensors for monitoring health parameters. Notable examples consist of the CGM attribute in A6 TouchCare System (Medtrum Technologies) and MiniMed Insulin pumps (Medtronic).